Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Dec;21(12):879-84.
doi: 10.1002/clc.4960211204.

Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects

J L Mehta  1
Affiliations
Review

Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects

J L Mehta. Clin Cardiol. 1998 Dec.

Abstract

Aspirin is widely used in the treatment and prevention of coronary artery disease (CAD). However, other platelet inhibitory agents, which inhibit platelet activation, have not been found to be effective or as effective as aspirin. The discrepancy between the efficacy of these compounds and aspirin suggests that the therapeutic efficacy of aspirin may not be limited to its platelet inhibitory effect. In this review, the basis for a unique place for aspirin in the therapy of patients with CAD is discussed. The author believes that the nonplatelet-mediated effects of aspirin could be more important than the platelet inhibitory effect, or at least may complement the platelet inhibitory effects of aspirin in patients with acute myocardial ischemia and in others undergoing intracoronary procedures.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

References

    1. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature (London) 1993; 326: 801–809 - PubMed
    1. Mehta JL, Mehta, P , Pepine CJ: Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. III. Role of tachycardia stress and propranolol. Circulation 1978; 58: 881–886 - PubMed
    1. Mehta, JL , Mehta P, Burger C, Pepine CJ: Platelet aggregation studies in coronary artery disease. IV. Effect of aspirin. Atherosclerosis 1978; 31: 169–175 - PubMed
    1. Folts JD, Crowell EB Jr, Rowe GG: Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54: 365–370 - PubMed
    1. Golino P, Ashton JH, Buja LM, Rosolowsky M, Taylor AL, McNatt J, Campbell WB, Willerson JT: Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Circulation 1989; 79: 154–166 - PubMed

MeSH terms

Substances